Skip to main content
. Author manuscript; available in PMC: 2016 Aug 25.
Published in final edited form as: Mol Neurobiol. 2015 Jun 9;52(2):979–984. doi: 10.1007/s12035-015-9243-x

Table 2.

Results of DDFPe treatment prior to tPA delivery at 9 h

Group Sex BW (kg) Embolic site of occlusion NAS Time at sacrifice (h)a Infarct volume (%) Visible hemorrhage
Control M 3.6 MCA/ACA 18 12 21.89 Yes
Control M 3.7 MCA 17 4 9.15 No
Control F 3.4 MCA 18 7 5.61 No
Control F 3.4 MCA/ACA 1 24 4.28 No
Control F 4.2 MCA 18 9 4.5 No
tPA 9 h F 4 MCA 0 24 2.1 No
tPA 9 h M 4.5 MCA/ACA 0 24 1.06 No
tPA 9 h F 4.4 MCA 2 24 2.13 Yes
tPA 9 h F 4.5 MCA 2 24 1.91 Yes
tPA 9 h F 4.2 MCA 9 24 2.32 Yes
tPA 9 h M 4.2 MCA 9 24 2.46 Yes
tPA 9 h F 4.7 MCA 0 24 2.67 Yes
tPA 9 h F 4.4 MCA 9 24 3.23 Yes
tPA 9 h F 4.4 MCA 15 9 2.33 Yes
tPA 9 h F 4.4 MCA 14 5 1.76 No
tPA 9 h F 3.9 MCA 18 12 13.16 Yes
DDFPe + PA 9 h M 4.4 MCA 0 24 0.28 No
DDFPe + PA 9 h M 4 MCA 0 24 0.52 No
DDFPe + tPA 9 h M 4.5 MCA 0 24 0.99 No
DDFPe + tPA 9 h F 4.2 MCA 0 24 0 No
DDFPe + tPA 9 h M 4.4 MCA 0 24 1.92 No
DDFPe + tPA 9 h M 3.9 MCA/ACA 0 24 0.28 Yes
DDFPe + tPA 9 h M 3.8 MCA/ACA 0 24 1.62 Yes
a

Sacrifice was scheduled at 24 h unless early collections were due to severe symptoms